Literature DB >> 31630803

Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.

Amélie Decourcelle1, Ingrid Loison1, Steffi Baldini2, Dominique Leprince1, Vanessa Dehennaut3.   

Abstract

O-GlcNAcylation is a post-translational modification of thousands of intracellular proteins that dynamically regulates many fundamental cellular processes. Cellular O-GlcNAcylation levels are regulated by a unique couple of enzymes: O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), which adds and removes the GlcNAc residue, respectively. Maintenance of O-GlcNAc homeostasis is essential to ensure optimal cellular function and disruption of this homeostasis has been linked to the etiology of several human diseases including cancer. The mechanisms through which the cell maintains O-GlcNAc homeostasis are not fully understood but several studies have suggested that a reciprocal regulation of OGT and OGA expression could be one of them. In this study, we investigated the putative regulation of OGT and OGA expression in response to disruption in O-GlcNAc homeostasis in colon. We provide in vitro and in vivo evidences that in colon cells, modulation of O-GlcNAcylation levels leads to a compensatory regulation of OGT and OGA expression in an attempt to restore basal O-GlcNAcylation levels. Our results also suggests that the regulation of colonic OGA expression in response to changes in O-GlcNAc homeostasis occurs mostly at the transcriptional level whereas OGT regulation seems to rely mainly on post-transcriptional mechanisms.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colon; O-GlcNAc homeostasis; O-GlcNAc transferase; O-GlcNAcase

Mesh:

Substances:

Year:  2019        PMID: 31630803     DOI: 10.1016/j.bbrc.2019.10.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer.

Authors:  Ninon Very; Stéphan Hardivillé; Amélie Decourcelle; Julien Thévenet; Madjid Djouina; Adeline Page; Gérard Vergoten; Céline Schulz; Julie Kerr-Conte; Tony Lefebvre; Vanessa Dehennaut; Ikram El Yazidi-Belkoura
Journal:  Oncogene       Date:  2021-11-29       Impact factor: 9.867

Review 2.  O-GlcNAcylation regulation of cellular signaling in cancer.

Authors:  Lorela Ciraku; Emily M Esquea; Mauricio J Reginato
Journal:  Cell Signal       Date:  2021-11-17       Impact factor: 4.315

3.  New Insights Into the Biology of Protein O-GlcNAcylation: Approaches and Observations.

Authors:  Toni Mueller; Xiaosen Ouyang; Michelle S Johnson; Wei-Jun Qian; John C Chatham; Victor Darley-Usmar; Jianhua Zhang
Journal:  Front Aging       Date:  2021-03-12

4.  Disruption of O-GlcNAcylation Homeostasis Induced Ovarian Granulosa Cell Injury in Bovine.

Authors:  Teng-Fei Wang; Zhi-Qiang Feng; Ya-Wen Sun; Shan-Jiang Zhao; Hui-Ying Zou; Hai-Sheng Hao; Wei-Hua Du; Xue-Ming Zhao; Hua-Bin Zhu; Yun-Wei Pang
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

5.  NAT10 Maintains OGA mRNA Stability Through ac4C Modification in Regulating Oocyte Maturation.

Authors:  Jiayu Lin; Yuting Xiang; Jiana Huang; Haitao Zeng; Yanyan Zeng; Jiawen Liu; Taibao Wu; Qiqi Liang; Xiaoyan Liang; Jingjie Li; Chuanchuan Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

6.  Exploring the Potential of β-Catenin O-GlcNAcylation by Using Fluorescence-Based Engineering and Imaging.

Authors:  Angelina Kasprowicz; Corentin Spriet; Christine Terryn; Vincent Rigolot; Stephan Hardiville; Matthew G Alteen; Tony Lefebvre; Christophe Biot
Journal:  Molecules       Date:  2020-10-01       Impact factor: 4.411

7.  Feedback Regulation of O-GlcNAc Transferase through Translation Control to Maintain Intracellular O-GlcNAc Homeostasis.

Authors:  Chia-Hung Lin; Chen-Chung Liao; Mei-Yu Chen; Teh-Ying Chou
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.